Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report

C. Tsien; S. Pugh; A.P. Dicker; J.J. Raizer; M.M. Matuszak; E. Lallana; J. Huang; O. Algan; N. Taylor; L. Portelance; J. Villano; J. Hamm; K.S. Oh; A.N. Ali; M.M. Kim; S. Lindhorst; M.P. Mehta

doi:10.1016/j.ijrobp.2019.06.539

Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report

C. Tsien, S. Pugh, A.P. Dicker, J.J. Raizer, M.M. Matuszak, E. Lallana, J. Huang, O. Algan, N. Taylor, L. Portelance, J. Villano, J. Hamm, K.S. Oh, A.N. Ali, M.M. Kim, S. Lindhorst, M.P. Mehta

Research output: Contribution to conference › Presentation

Original language	American English
DOIs	https://doi.org/10.1016/j.ijrobp.2019.06.539
State	Published - Sep 1 2019
Event	International Journal of Radiation Oncology Biology Physics - Duration: Sep 1 2019 → …

Conference

Conference	International Journal of Radiation Oncology Biology Physics
Period	9/1/19 → …

Disciplines

Oncology
Radiology
Internal Medicine
Medicine and Health Sciences

Access to Document

10.1016/j.ijrobp.2019.06.539License: Unspecified

Cite this

Tsien, C., Pugh, S., Dicker, A. P., Raizer, J. J., Matuszak, M. M., Lallana, E., Huang, J., Algan, O., Taylor, N., Portelance, L., Villano, J., Hamm, J., Oh, K. S., Ali, A. N., Kim, M. M., Lindhorst, S., & Mehta, M. P. (2019). Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report. International Journal of Radiation Oncology Biology Physics. https://doi.org/10.1016/j.ijrobp.2019.06.539

Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report. / Tsien, C.; Pugh, S.; Dicker, A.P. et al.
2019. International Journal of Radiation Oncology Biology Physics.

Research output: Contribution to conference › Presentation

Tsien, C, Pugh, S, Dicker, AP, Raizer, JJ, Matuszak, MM, Lallana, E, Huang, J, Algan, O, Taylor, N, Portelance, L, Villano, J, Hamm, J, Oh, KS, Ali, AN, Kim, MM, Lindhorst, S & Mehta, MP 2019, 'Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report', International Journal of Radiation Oncology Biology Physics, 9/1/19. https://doi.org/10.1016/j.ijrobp.2019.06.539

Tsien C, Pugh S, Dicker AP, Raizer JJ, Matuszak MM, Lallana E et al.. Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report. 2019. International Journal of Radiation Oncology Biology Physics. doi: 10.1016/j.ijrobp.2019.06.539

@conference{f23db1c8fec043eea7b7aed8a2cc1b37,

title = "Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report",

author = "C. Tsien and S. Pugh and A.P. Dicker and J.J. Raizer and M.M. Matuszak and E. Lallana and J. Huang and O. Algan and N. Taylor and L. Portelance and J. Villano and J. Hamm and K.S. Oh and A.N. Ali and M.M. Kim and S. Lindhorst and M.P. Mehta",

year = "2019",

month = sep,

day = "1",

doi = "10.1016/j.ijrobp.2019.06.539",

language = "American English",

note = "International Journal of Radiation Oncology Biology Physics ; Conference date: 01-09-2019",

}

TY - CONF

T1 - Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report

AU - Tsien, C.

AU - Pugh, S.

AU - Dicker, A.P.

AU - Raizer, J.J.

AU - Matuszak, M.M.

AU - Lallana, E.

AU - Huang, J.

AU - Algan, O.

AU - Taylor, N.

AU - Portelance, L.

AU - Villano, J.

AU - Hamm, J.

AU - Oh, K.S.

AU - Ali, A.N.

AU - Kim, M.M.

AU - Lindhorst, S.

AU - Mehta, M.P.

PY - 2019/9/1

Y1 - 2019/9/1

UR - https://www.redjournal.org/article/S0360-3016(19)31374-4/fulltext

U2 - 10.1016/j.ijrobp.2019.06.539

DO - 10.1016/j.ijrobp.2019.06.539

M3 - Presentation

T2 - International Journal of Radiation Oncology Biology Physics

Y2 - 1 September 2019

ER -

Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report

Conference

Disciplines

Access to Document

Other files and links

Cite this